Gene · 6595
Papers3,459
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,459
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HDAC inhibition induces EMT and alterations in cellular iron homeostasis to augment ferroptosis sensitivity in SW13 cells. | Redox Biol | 2021 | 34600336 | PubTator, text mining | PubMed |
| Comprehensive characterization and clinical relevance of the SWI/SNF copy number aberrations across human cancers. | Hereditas | 2021 | 34598711 | PubTator, text mining | PubMed |
| Chromatin remodeling in oligodendrogenesis. | Vavilovskii Zhurnal Genet Selektsii | 2021 | 34595379 | PubTator, text mining | PubMed |
| A protein interaction landscape of breast cancer. | Science | 2021 | 34591612 | PubTator, text mining | PubMed |
| Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer. | Cancer Metastasis Rev | 2021 | 34591242 | PubTator, text mining | PubMed |
| Interplay of m6 A and histone modifications contributes to temozolomide resistance in glioblastoma. | Clin Transl Med | 2021 | 34586728 | PubTator, text mining | PubMed |
| Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | J Endocr Soc | 2021 | 34585037 | PubTator, text mining | PubMed |
| Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma. | Pharmaceuticals (Basel) | 2021 | 34577604 | PubTator, text mining | PubMed |
| Mutations in Epigenetic Regulation Genes in Gastric Cancer. | Cancers (Basel) | 2021 | 34572812 | PubTator, text mining | PubMed |
| Stationed or Relocating: The Seesawing EMT/MET Determinants from Embryonic Development to Cancer Metastasis. | Biomedicines | 2021 | 34572451 | PubTator, text mining | PubMed |
| Epigenetic Mechanisms Underlying COVID-19 Pathogenesis. | Biomedicines | 2021 | 34572329 | PubTator, text mining | PubMed |
| Somatic Mutation Analysis in Salix suchowensis Reveals Early-Segregated Cell Lineages. | Mol Biol Evol | 2021 | 34562099 | PubTator, text mining | PubMed |
| Tissue-Resident-Memory CD8+ T Cells Bridge Innate Immune Responses in Neighboring Epithelial Cells to Control Human Genital Herpes. | Front Immunol | 2021 | 34552595 | PubTator, text mining | PubMed |
| Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia. | Cell Rep | 2021 | 34551306 | PubTator, text mining | PubMed |
| PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation. | Cell Rep | 2021 | 34551289 | PubTator, text mining | PubMed |
| SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria. | Nat Commun | 2021 | 34518526 | PubTator, text mining | PubMed |
| Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. | Clin Cancer Res | 2021 | 34518313 | PubTator, text mining | PubMed |
| Synchronous Malignant Gastrointestinal Neuroectodermal Tumor and SMARCA4-Deficient Undifferentiated Carcinoma With Independent Origins in the Small Intestine: A Case Report. | Front Oncol | 2021 | 34513665 | PubTator, text mining | PubMed |
| Intermediate between Idiopathic Hypereosinophilia and Chronic Eosinophilic Leukemia: A Report of Two Hypereosinophilic Cases with Possible Novel Molecular Mutations. | Case Rep Hematol | 2021 | 34513100 | PubTator, text mining | PubMed |
| Chromoanagenesis Event Underlies a de novo Pericentric and Multiple Paracentric Inversions in a Single Chromosome Causing Coffin-Siris Syndrome. | Front Genet | 2021 | 34512724 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6595/papers?page=50